Billionaire Platt-Backed Engitix Inks $300 Million Takeda Deal
(Bloomberg) -- U.K.-based biotech firm Engitix Ltd. and Japanese drugmaker Takeda Pharmaceutical Co. have agreed to extend their existing partnership in a deal could be valued at as much as $300 million.
Source: bloombergquint.com